Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neutral sphingomyelinase (N-SMase) is one of the key enzymes involved in the generation of ceramide; however, the gene(s) encoding for the mammalian N-SMase is still not well defined. Previous studies on the cloned nSMase1 had shown that the protein acts primarily as lyso-platelet-activating factor-
phospholipase C
. Recently the cloning of another putative N-SMase,
nSMase2
, was reported. In this study, biochemical characterization of the mouse
nSMase2
was carried out using the overexpressed protein in yeast cells in which the inositol phosphosphingolipid
phospholipase C
(Isc1p) was deleted. N-SMase activity was dependent on Mg(2+) and was activated by phosphatidylserine and inhibited by GW4869. The ability of
nSMase2
to recognize endogenous sphingomyelin (SM) as substrate was investigated by overexpressing
nSMase2
in MCF7 cells. Mass measurements showed a 40% decrease in the SM levels in the overexpressor cells, and labeling studies demonstrated that
nSMase2
accelerated SM catabolism. Accordingly, ceramide measurement showed a 60 +/- 15% increase in
nSMase2
-overexpressing cells compared with the vector-transfected MCF7. The role of
nSMase2
in cell growth was next investigated. Stable overexpression of
nSMase2
resulted in a 30-40% decrease in the rate of growth at the late exponential phase. Moreover, tumor necrosis factor induced approximately 50% activation of
nSMase2
in MCF7 cells overexpressing the enzyme, demonstrating that
nSMase2
is a tumor necrosis factor-responsive enzyme. In conclusion, these results 1) show that
nSMase2
is a structural gene for nSMase, 2) suggest that
nSMase2
acts as a bona fide N-SMase in cells, and 3) implicate
nSMase2
in the regulation of cell growth and cell signaling.
...
PMID:Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. 1256 38
Sphingosylphosphocholine (SPC), the N-deacylated form of sphingomyelin (SM), is a naturally occurring lipid mediator. However, little is known about the metabolism of SPC. We here report an in vitro assay system for SPC-
phospholipase C
(
PLC
). Using this assay system, we demonstrated that nSMase1 and
nSMase2
, human neutral sphingomyelinases (SMases), are capable of hydrolyzing SPC efficiently under detergent-free conditions. Bacterial and plasmodial neutral SMases also showed SPC-
PLC
activity. The substrate specificity of neutral SMases that hydrolyze SM, SPC, and monoradyl glycerophosphocholine, but not diradyl glycerophosphocholine, suggested that a hydrogen-bond donor at the C-2 or sn-2 position in the substrate is required for recognition by the enzymes.
...
PMID:Hydrolysis of sphingosylphosphocholine by neutral sphingomyelinases. 1474 83